Kronox Lab Sciences working capital

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
57.76×57.76×56.00×73.65×
74.06×74.06×68.37×71.68×
25.79×25.79×22.38×49.69×
106.03×106.03×101.99×95.64×
1.54×1.48×1.60×2.31×
0.89×0.89×1.16×1.21×
0.86×0.86×1.28×0.82×
0.70×0.70×0.98×0.61×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KRONOX₹191.75

Kronox Lab Sciences Limited

· Chemicals
₹ CrorePeersJAYAGROGNDMCCSRHHYPOLTDCHEMFABPRIMOPLASTIBLENGEMAROMASUDARCOLORMcap ₹711 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)73.6556.0057.7657.76
Receivable Days (DSO)71.6868.3774.0674.06
Payable Days (DPO)49.6922.3825.7925.79
Cash Conversion Cycle (days)95.64101.99106.03106.03
Working Capital Turnover2.311.601.481.54
Asset Turnover1.211.160.890.89
Cash Conversion (CFO/Net Income)0.821.280.860.86
CFO/EBITDA0.610.980.700.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.